The performance of the NHS has come under the spotlight once again, following figures showing worst-ever performances against waiting times targets for cancer treatment and in A&E.
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment